Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021
Mitsuhide NaruseTakuyuki KatabamiHirotaka ShibataMasakatsu SoneKatsutoshi TakahashiAkiyo TanabeShoichiro IzawaTakamasa IchijoMichio OtsukiMasao OmuraYoshihiro OgawaYutaka OkiIsao KuriharaHiroki KobayashiRyuichi SakamotoFumitoshi SatohYoshiyu TakedaTomoaki TanakaKouichi TamuraMika TsuikiShigeatsu HashimotoTomonobu HasegawaTakanobu YoshimotoTakashi YonedaKoichi YamamotoHiromi RakugiNorio WadaAya SaikiYouichi OhnoTatsuya Haze
Author information

2022 Volume 69 Issue 4 Pages 327-359


Primary aldosteronism (PA) is associated with higher cardiovascular morbidity and mortality rates than essential hypertension. The Japan Endocrine Society (JES) has developed an updated guideline for PA, based on the evidence, especially from Japan. We should preferentially screen hypertensive patients with a high prevalence of PA with aldosterone to renin ratio ≥200 and plasma aldosterone concentrations (PAC) ≥60 pg/mL as a cut-off of positive results. While we should confirm excess aldosterone secretion by one positive confirmatory test, we could bypass patients with typical PA findings. Since PAC became lower due to a change in assay methods from radioimmunoassay to chemiluminescent enzyme immunoassay, borderline ranges were set for screening and confirmatory tests and provisionally designated as positive. We recommend individualized medicine for those in the borderline range for the next step. We recommend evaluating cortisol co-secretion in patients with adrenal macroadenomas. Although we recommend adrenal venous sampling for lateralization before adrenalectomy, we should carefully select patients rather than all patients, and we suggest bypassing in young patients with typical PA findings. A selectivity index ≥5 and a lateralization index >4 after adrenocorticotropic hormone stimulation defines successful catheterization and unilateral subtype diagnosis. We recommend adrenalectomy for unilateral PA and mineralocorticoid receptor antagonists for bilateral PA. Systematic as well as individualized clinical practice is always warranted. This JES guideline 2021 provides updated rational evidence and recommendations for the clinical practice of PA, leading to improved quality of the clinical practice of hypertension.

Content from these authors
© The Japan Endocrine Society
Next article